Newsletter January 2018: Positive Feedback from European Stroke Science Workshop in Garmisch On 16 – 18 November 2017 international stroke experts met for the biannually European Stroke Science Workshop in Eibsee near Garmisch Partenkirchen, Germany. We received a lot of positive feedback for the SWITCH trial and it was very encouraging to hear that the stroke expert community is still highly committed to SWITCH. This gives us even more motivation to advance the trial and we are convinced that together we will bring this trial to a successful end.
Winter impression showing Eibsee with the top of Zugspitze in the background Image: Jürgen Beck, Nov. 2017
www.switch-trial.ch
Current patient accrual (03.01.2018) Randomized trial: 63 Observational arm: 10
Top recruiting sites 1. Bern (11 patients randomized) 2. Berlin (9 patients randomized, 1 patient in observational arm) 3. Helsinki (8 patients randomized, 1 patient in observational arm) 4. Aachen (6 patients randomized) 5. Giessen (4 patients randomized, 2 patients in observational arm)
SWITCH sites Currently we have 30 sites open for the recruitment of patients.
Recruiting Coming soon Planned
Aachen, Amsterdam, Bellvitge Hospital Barcelona, Bern, Berlin, Bonn, Düsseldorf, Erlangen, Erfurt, Essen, Frankfurt, Freiburg, Geneva, Giessen, Göttingen, Helsinki, Innsbruck, Kassel, Linz, Madrid, Mainz, Mannheim, München, Münster, Lübeck, Lucerne, Lugano, Sevilla, Utrecht, Würzburg Paris, Barcelona Santa Creu i Sant Pau, Edinburgh Siegen
Sponsor Investigators and local PIs Bern
Prof. Dr. med. Jürgen Beck
[email protected] Phone: +41 31 632 24 09
Investigator Bern
PD Dr. med. Christian Fung
[email protected] Phone: +41 31 632 35 37
Trial Management NCTU
Dr. phil. II Stefanie Lerch
[email protected] Phone: +41 31 632 73 09
Trial Coordination NCTU
Lena Burkhardt, MSc
[email protected] Phone: +41 31 632 60 83
Please follow us on www.Researchgate.net
www.switch-trial.ch
Prof. Dr. med. Urs Fischer
[email protected] Phone: +41 31 632 03 64
